T1	Protein 131 135	IL-2
T2	Protein 223 227	CD28
T3	Protein 274 278	IL-2
T4	Protein 500 505	c-Jun
T5	Protein 1176 1181	c-Jun
T6	Protein 1483 1487	CD28
T7	Protein 1650 1655	c-Jun
T51	Exp 350 373	Protein phosphorylation
T52	Exp 591 601	NF-kappa B
T53	Exp 966 970	TPCK
T54	Exp 1319 1338	a signaling pathway
R8	Coref Anaphora:T12 Antecedent:T3
R9	Coref Anaphora:T13 Antecedent:T51
R10	Coref Anaphora:T20 Antecedent:T52
R11	Coref Anaphora:T31 Antecedent:T53
R12	Coref Anaphora:T32 Antecedent:T34
R13	Coref Anaphora:T38 Antecedent:T54
R14	Coref Anaphora:T42 Antecedent:T46
T8	Exp 95 123	The transcriptional activity
T9	Exp 127 144	the IL-2 promoter
T10	Exp 188 195	the TCR
T11	Exp 200 222	the auxiliary receptor
T12	Exp 306 311	which
T13	Exp 440 442	it
T14	Exp 515 517	it
T15	Exp 399 413	the regulation
T16	Exp 451 479	the transactivating capacity
T17	Exp 483 499	the AP-1 protein
T18	Exp 533 544	the release
T19	Exp 548 573	the cytoplasmic inhibitor
T20	Exp 629 639	the latter
T21	Exp 645 656	the nucleus
T22	Exp 417 434	these two factors
T23	Exp 658 660	We
T24	Exp 681 685	that
T25	Exp 686 690	both
T26	Exp 782 794	the kinetics
T27	Exp 798 828	the two phosphorylation events
T28	Exp 867 878	our results
T29	Exp 889 912	the kinases responsible
T30	Exp 917 934	the two processes
T31	Exp 1054 1056	it
T32	Exp 1126 1130	that
T33	Exp 1075 1087	the activity
T34	Exp 1096 1125	the MAP kinase-related kinase
T35	Exp 1146 1172	the transactivation domain
T36	Exp 1183 1185	We
T37	Exp 1206 1227	the activation scheme
T38	Exp 1339 1343	that
T39	Exp 1301 1315	the activation
T40	Exp 1353 1379	the simultaneous induction
T41	Exp 1383 1412	the two transcription factors
T42	Exp 1526 1531	which
T43	Exp 1450 1461	the signals
T44	Exp 1613 1625	the one hand
T45	Exp 1675 1684	the other
T46	Exp 1512 1524	this pathway
T47	Exp 1686 1688	We
T48	Exp 1723 1728	where
T49	Exp 1729 1744	the two signals
T50	Exp 1761 1788	the AP-1/NF-kappa B pathway
